Radiation therapy used after surgical excision of keloid acne scars significantly reduces the risk of scar regrowth, achieving approximately 80% success rates compared to surgery alone, which carries a 45-100% recurrence risk. When properly timed and dosed, this combined approach can virtually eliminate keloid recurrence. For someone who has struggled with a large keloid acne scar on their chest or back—a common occurrence in people prone to keloid formation—radiation therapy administered within 24-48 hours after surgical excision offers a substantial improvement in long-term outcomes. This article explains how radiation works after excision, what the success rates actually look like, which treatment schedules are most effective, and what patients should realistically expect during recovery.
Table of Contents
- How Radiation Therapy Prevents Keloid Regrowth After Surgical Removal
- Recurrence Rates and Long-Term Success Data for Excision Plus Radiation
- Radiation Dosage, Fractionation Schedules, and Dose-Response Relationships
- Comparing Radiation Modality Types and Their Effectiveness
- Timing of Radiation After Surgery, Safety Profile, and Adverse Effects
- Anatomical Location Significantly Affects Keloid Recurrence Risk
- Acne-Related Keloids and Radiation Therapy Outcomes
- Conclusion
How Radiation Therapy Prevents Keloid Regrowth After Surgical Removal
Radiation therapy works by damaging the fibroblasts and blood vessels involved in abnormal scar formation. Surgery alone removes the keloid, but the underlying biological tendency to overproduce scar tissue remains. By delivering targeted radiation to the excision site immediately after surgery, while the wound is fresh, radiation prevents the aggressive fibroblast proliferation that leads to keloid recurrence.
The timing is critical—same-day or next-day radiation is significantly more effective than waiting weeks after surgery. This combination approach addresses both the mechanical problem (removing the visible keloid) and the biological problem (stopping the abnormal healing response that creates keloids). For acne scars that have progressed to keloid formation, this dual strategy is particularly important because acne-prone skin is already predisposed to abnormal wound healing. A person who had severe acne and developed a raised, expanding keloid scar on their shoulder or jawline would benefit from this approach far more than from excision alone.
Recurrence Rates and Long-Term Success Data for Excision Plus Radiation
The overall recurrence rate for excision combined with adjuvant radiation therapy is approximately 20%, compared to much higher rates for surgery alone. However, this figure varies significantly by follow-up duration and study population. One large institutional study with a median follow-up of 40 months reported only 5.6% recurrence for all lesions treated. A more recent 2-year follow-up study found 12.7% recurrence at 18 months, but importantly, the cure rate reached 85.6% from 24 months onward, meaning that late recurrences became increasingly rare.
This distinction matters because it means most recurrences happen early, and if a keloid stays stable for two years after treatment, the odds of it returning are very low. These success rates represent a dramatic improvement over excision without radiation. However, the 20% recurrence figure is a median—individual patients’ outcomes depend heavily on the radiation dose delivered, the modality used, and crucially, the anatomical location of the scar. A keloid on the earlobe has far better odds than one on the chest, a distinction that is sometimes overlooked when discussing success rates broadly.
Radiation Dosage, Fractionation Schedules, and Dose-Response Relationships
The most effective radiation treatment schedule is 3 fractions of 6 Gy (Gray) each, delivered on days 1, 2, and 3 after surgery, for a total of 18 Gy. This fractionated schedule is equivalent to a biologically effective dose (BED) of 30 Gy and has become the standard in many treatment centers. An alternative approach uses 20 Gy delivered in 5 daily fractions, which achieved 90% local control and excellent cosmetic outcomes at mean follow-up of 35 months in one institutional experience. Dose matters significantly.
Lesions treated to 20 Gy or higher show only 1.6% recurrence rates, compared to 9.6% recurrence in lesions receiving less than 20 Gy—a difference with a strong statistical significance (P=.02). In practical terms, this means underdosing a keloid substantially increases the risk that it will return. Studies generally agree that a BED of 30 Gy or above correlates with the lowest recurrence rates, which is why the 3 × 6 Gy schedule has become standard practice. However, there is a tradeoff: higher doses may increase the risk of late cosmetic effects, though this remains less common than keloid recurrence.
Comparing Radiation Modality Types and Their Effectiveness
Different types of radiation deliver the dose differently, and their effectiveness varies. A meta-analysis examining 106 studies involving 10,745 lesions found that brachytherapy (internal radiation placed directly at the wound site) achieved the lowest recurrence rate at 15%, followed by electron beam therapy at 16% recurrence, and X-ray therapy at 18% recurrence. The differences are modest, but they suggest that brachytherapy may have a small edge in preventing recurrence. The choice of modality often depends on institutional availability and technical factors rather than dramatic differences in outcome.
Electron beam therapy, for example, is advantageous because it delivers dose precisely to the skin surface and tissues immediately below, with minimal dose to deeper structures—a meaningful advantage when treating facial or neck scars where you want to avoid deeper tissue effects. Brachytherapy requires specialized training and involves placing a temporary radioactive source at the surgical site. X-ray therapy (conventional external beam) is widely available but slightly less efficient at controlling dose distribution. For most patients, the most important factor is not the modality type but ensuring the dose is adequate (at least 20 Gy) and delivered on schedule.
Timing of Radiation After Surgery, Safety Profile, and Adverse Effects
Radiation should ideally be delivered within 24-48 hours after surgical excision, while the tissue is still fresh and healing has just begun. The exact necessity of adhering strictly to a 24-hour window remains somewhat debated in the literature, but the evidence strongly supports same-day or next-day delivery as more effective than delaying radiation by weeks. This requirement has practical implications: it means the surgery and radiation facility need to coordinate closely, and some patients may need to return the day after surgery for treatment. The safety profile of post-excisional radiation for keloids is generally favorable.
Transient hyperpigmentation (darkening of the skin in the treated area) was the most frequent adverse effect reported. Importantly, no malignancies have been reported in the treated area during follow-up evaluations in the published literature. The radiation doses and fields used are small and precisely targeted, not the large-field, high-dose therapy used in cancer treatment, which substantially reduces the theoretical risk of radiation-induced complications. Some patients report mild temporary redness or swelling, similar to a mild sunburn, which resolves within weeks.
Anatomical Location Significantly Affects Keloid Recurrence Risk
The location of the keloid dramatically influences recurrence risk after treatment. Keloids on the ear show only 12% recurrence after excision and radiation, among the lowest rates observed. In contrast, keloids on the chest and trunk show 34% recurrence—nearly three times higher. This anatomical variation is thought to relate to differences in wound tension, blood supply, and the inherent biological propensity of different body regions to form excessive scar tissue.
For someone with an acne-related keloid, location is therefore critical information. A keloid that developed from a severe acne breakout on the chest or back carries a higher recurrence risk than one on the face or neck, even with identical radiation treatment. This should inform the discussion between patient and provider about treatment options and realistic expectations. Some patients with high-risk locations (trunk, chest, shoulders) may benefit from additional preventive measures beyond radiation, such as pressure garments or topical silicone, though radiation remains the most effective single intervention.
Acne-Related Keloids and Radiation Therapy Outcomes
Keloids can develop as a consequence of severe acne scarring, particularly in individuals with darker skin tones or a genetic predisposition to abnormal wound healing. Recent literature from 2025 specifically documents cases of acne keloidalis treated successfully with superficial radiation therapy, confirming that this approach is effective for acne-related keloids, not just keloids from other causes. The same principles apply: excision removes the bulk of the scar, and radiation prevents the regrowth that would otherwise occur in acne-prone, keloid-prone skin.
Understanding this mechanism is valuable for long-term prevention. While radiation therapy prevents keloid recurrence, it does not prevent new acne from forming or new scars from acne. Ongoing acne management—whether through topical treatments, oral medications, or dermatology care—remains essential to prevent new keloids from developing elsewhere on the body. A patient who treats a large acne keloid with excision and radiation but continues to have severe acne without treatment may simply develop new keloids elsewhere within a few years.
Conclusion
Radiation therapy delivered within 24-48 hours after surgical excision of keloid acne scars is the most effective available treatment, reducing the recurrence risk from 45-100% (surgery alone) to approximately 20% overall, with some institutional studies reporting recurrence rates as low as 5-6%. The most effective approach uses 18-20 Gy delivered in 3-5 fractions, achieving 80% or higher long-term success rates. Outcomes vary substantially by anatomical location, with scalp and trunk lesions carrying higher recurrence risk than facial or ear lesions.
If you have a keloid scar from acne and are considering treatment, discussing excision combined with adjuvant radiation with a dermatologist or surgical oncologist is warranted. The timing and coordination of these treatments are important, so selecting a facility experienced in this combined approach will optimize your results. Beyond the immediate treatment, continued acne management is essential to prevent new keloid formation from future acne breakouts.
